PERMANENT AWARD EVIDENCE
University College London Hospitals NHS Foundation Trust · published 5 Mar 2025. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.
e93c035b-9514-44f6-b461-5f0e6cc4b49b-832083ocds-b5fd17-b0293d34-ece5-4549-9adc-6d396d33200aGB-CFS-311653A tender estimate and an award value answer different questions. Neither is treated as cash paid.
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.
A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.
No supplier is named in this projection. That does not prove the notice had no supplier in every source version.
Published 5 Mar 2025 · held through the daily award projection · Open Government Licence v3.0.